Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenase for SIRS and Organ Dysfunction After Heart Surgery
NCT01141556Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Dec 2010
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of selenium in Systemic Inflammatory Response Syndrome (SIRS) and organ dysfunction, sponsored by University Hospital Basel. Primary endpoint: Sequential Organ Failure Assessment at 3 days. Started Dec 2010; status: completed.
02
Drugs
selenium
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)organ dysfunction
Beyond the preview
Go deeper on NCT01141556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01141556.